The Food and Drug Administration has investigated consumer reports of serious side effects since the recall of children’s drugs manufactured by McNeil Consumer Healthcare, a division of Johnson & Johnson. On Tuesday the company hired a consulting firm to look into the problems in its factory, according to The Associated Press (AP).
On April 30, 2010, McNeil implemented a voluntary Tylenol recall, specifically its liquid children’s versions of the drug, as well as similar products of Motrin, Zyrtec, and Benadryl. The company said the recall was initiated as a precautionary measure when it was discovered that products had not met quality standards.
In McNeil’s press release regarding the recall, the company said, “Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.”
CNN reported that since the Tylenol recall, a source close to the congressional investigation into the matter has told them that at least 775 serious side effects were reported by consumers. The FDA investigated these reports, known as “adverse events.” The House Committee on Oversight and Government Reform has scheduled a hearing for this Thursday, May 27, with Johnson & Johnson’s president for consumer products, Colleen Goggins.
This follows a 17-page report released by the FDA earlier this month, which detailed instances of McNeil’s factory in Fort Washington, Pennsylvania, neglecting to conduct proper quality control tests and lacking transparency in production procedures. Production in the factory was suspended. It is the only factory in the company that produces liquid children’s drugs, according to CNN.
A Fortune 500 company, Johnson & Johnson is facing setbacks in its reputation after the Tylenol, Motrin, Zyrtec and Benadryl recall.